Staging of brain pathology related to sporadic Parkinson’s disease

[1]  F. Lewy.  Paralysis agitans. I. Pathologische Anatomie , 1912 .

[2]  W. G. Cochran.  Some Methods for Strengthening the Common χ 2 Tests , 1954 .

[3]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[4]  L. Forno,et al.  CONCENTRIC HYALIN INTRANEURONAL INCLUSIONS OF LEWY TYPE IN THE BRAINS OF ELDERLY PERSONS (50 INCIDENTAL CASES): RELATIONSHIP TO PARKINSONISM , 1969, Journal of the American Geriatrics Society.

[5]  R. R. Sturrock,et al.  Problems of the Keimbahn: New Work on Mammalian Germ Cell Lineage , 1985 .

[6]  C. Tanner,et al.  Autonomic dysfunction in Parkinson's disease , 1986, Neurology.

[7]  H. Braak,et al.  Nuclear configuration and neuronal types of the nucleus niger in the brain of the human adult. , 1986, Human neurobiology.

[8]  A. Korczyn,et al.  Autonomic nervous system disturbances in Parkinson's disease. , 1990, Advances in neurology.

[9]  D. Irving,et al.  Lewy body prevalence in the aging brain: relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei , 1990, Journal of the Neurological Sciences.

[10]  K. Jellinger,et al.  Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. , 1991, Molecular and chemical neuropathology.

[11]  D. Dickson,et al.  Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease , 1991, Neurology.

[12]  W. Gibb,et al.  Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[13]  W. Gibb.  Neuropathology of the substantia nigra. , 1991, European neurology.

[14]  H. Braak,et al.  Demonstration of Amyloid Deposits and Neurofibrillary Changes in Whole Brain Sections , 1991, Brain pathology.

[15]  W. Gibb,et al.  Neuronal inclusions of Parkinson's disease , 1991, Movement disorders : official journal of the Movement Disorder Society.

[16]  K. Obata,et al.  Immunocytochemical localization of synaptic vesicle-specific protein in lewy body-containing neurons in Parkinson's disease , 1992, Neuroscience Letters.

[17]  H. Braak,et al.  The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases , 1992, Neuroscience Research.

[18]  G. Mckhann,et al.  Diseases of the Nervous System: Clinical Neurobiology , 1992 .

[19]  W. Koller,et al.  When does Parkinson's disease begin? , 1992, Neurology.

[20]  B. Snow,et al.  Criteria for diagnosing Parkinson's disease , 1992, Annals of neurology.

[21]  D. Dickson,et al.  Pathology and Biology of the Lewy Body , 1993, Journal of neuropathology and experimental neurology.

[22]  P. Delwaide,et al.  The audiospinal reaction in parkinsonian patients reflects functional changes in reticular nuclei , 1993, Annals of neurology.

[23]  G. Sawle.  The detection of preclinical Parkinson's disease: What is the role of positron emission tomography? , 1993, Movement disorders : official journal of the Movement Disorder Society.

[24]  R. Ravid,et al.  ‘Lewy body disease’: clinico-pathological correlations in 18 consecutive cases of Parkinson's disease with and without dementia , 1995, Clinical Neurology and Neurosurgery.

[25]  S. Daniel,et al.  The anterior olfactory nucleus in Parkinson's disease , 1995, Movement disorders : official journal of the Movement Disorder Society.

[26]  Dementia with Lewy Bodies: Pathological and clinical features of Parkinson's disease with and without dementia , 1996 .

[27]  Bernard Pillon,et al.  Cognitive deficits in Parkinson’s disease , 1996, Journal of Neurology.

[28]  Dementia with Lewy Bodies: Pathogenesis of the Lewy body , 1996 .

[29]  L. Forno,et al.  Neuropathology of Parkinson's Disease , 1996, Journal of neuropathology and experimental neurology.

[30]  K. Nakashima,et al.  Olfactory evoked potentials in Parkinson's disease, Alzheimer's disease and anosmic patients , 1996, Psychiatry and clinical neurosciences.

[31]  S. Daniel,et al.  Olfactory dysfunction in Parkinson's disease. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[32]  H. Braak,et al.  Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories , 1997, Neurobiology of Aging.

[33]  P. Moberg,et al.  Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. , 1998, Archives of neurology.

[34]  J. Trojanowski,et al.  Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia. , 1998, Archives of neurology.

[35]  W. Markesbery.  Neuropathology of dementing disorders , 1998 .

[36]  B. Hyman,et al.  Nigral and Cortical Lewy Bodies and Dystrophic Nigral Neurites in Parkinson's Disease and Cortical Lewy Body Disease Contain α-synuclein Immunoreactivity , 1998, Journal of neuropathology and experimental neurology.

[37]  J Q Trojanowski,et al.  Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. , 1998, The American journal of pathology.

[38]  B. Hyman.  New neuropathological criteria for Alzheimer disease. , 1998, Archives of neurology.

[39]  H. Braak,et al.  Silver staining method for demonstrating Lewy bodies in Parkinson’s disease and argyrophilic oligodendrocytes in multiple system atrophy , 1999, Journal of Neuroscience Methods.

[40]  J. Culvenor,et al.  α‐Synuclein Immunoisolation of Glial Inclusions from Multiple System Atrophy Brain Tissue Reveals Multiprotein Components , 1999, Journal of neurochemistry.

[41]  S. Daniel,et al.  Commentary Qjm Is Parkinson's Disease a Primary Olfactory Disorder? , 2022 .

[42]  A. Graybiel,et al.  The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. , 1999, Brain : a journal of neurology.

[43]  H. Braak,et al.  Alpha-synuclein immunoreactive Lewy bodies and Lewy neurites in Parkinson’s disease are detectable by an advanced silver-staining technique , 1999, Acta Neuropathologica.

[44]  D. Dickson.  Tau and Synuclein and Their Role in Neuropathology , 1999, Brain pathology.

[45]  S. Gilman,et al.  Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.

[46]  A. Graybiel,et al.  The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. , 1999, Brain : a journal of neurology.

[47]  H. Braak,et al.  Parkinson’s disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system , 2000, Acta Neuropathologica.

[48]  J. Valls-Solé.  Neurophysiological characterization of parkinsonian syndromes * Part of the author's research studies described here were supported by a grant from La Caixa, n° 97/0072. , 2000, Neurophysiologie Clinique/Clinical Neurophysiology.

[49]  C. Murphy,et al.  Event-related brain potentials to attended and ignored olfactory and trigeminal stimuli. , 2000, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[50]  H. Braak,et al.  Pathoanatomy of Parkinson’s disease , 2000, Journal of Neurology.

[51]  H. Berendse,et al.  Preclinical (premotor) Parkinson’s disease , 2000, Journal of Neurology.

[52]  H. Braak,et al.  Pathological Changes in the Parahippocampal Region in Select Non‐Alzheimer's Dementias , 2000, Annals of the New York Academy of Sciences.

[53]  J. Trojanowski,et al.  Neuropathology of synuclein aggregates , 2000, Journal of neuroscience research.

[54]  H. Braak,et al.  Alpha-synuclein is not a requisite component of synaptic boutons in the adult human central nervous system , 2000, Journal of Chemical Neuroanatomy.

[55]  J Q Trojanowski,et al.  Synucleinopathies: clinical and pathological implications. , 2001, Archives of neurology.

[56]  M. Goedert.  The significance of tau and α-synuclein inclusions in neurodegenerative diseases , 2001 .

[57]  H. Braak,et al.  Parkinson’s disease: the thalamic components of the limbic loop are severely impaired by α-synuclein immunopositive inclusion body pathology , 2002, Neurobiology of Aging.

[58]  Udo Rüb,et al.  Where Does Parkinson Disease Pathology Begin in the Brain? , 2002, Journal of neuropathology and experimental neurology.

[59]  G. Paxinos,et al.  THE HUMAN NERVOUS SYSTEM , 1975 .

[60]  P. Leigh,et al.  Relationships between Lewy bodies and pale bodies in Parkinson's disease , 2004, Acta Neuropathologica.

[61]  Kurt Jellinger,et al.  Amygdala pathology in Parkinson's disease , 2004, Acta Neuropathologica.

[62]  J. Trojanowski,et al.  Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease , 1994, Acta Neuropathologica.

[63]  Vincenzo Bonifati,et al.  Cardiovascular reflexes and autonomic dysfunction in parkinson's disease , 1991, Journal of Neurology.

[64]  E. Masliah,et al.  Cortical Lewy body-containing neurons are pyramidal cells: laser confocal imaging of double-immunolabeled sections with anti-ubiquitin and SMI32 , 2004, Acta Neuropathologica.

[65]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[66]  P. Delwaide,et al.  Functional changes of brainstem reflexes in Parkinson's disease conditioning of the blink reflex R2 component by paired and index finger stimulation , 2005, Journal of Neural Transmission.